An approach to malignant mammary phyllodes tumors detection

被引:4
|
作者
Ilic, Ivan [1 ]
Randelovic, Pavle [2 ]
Ilic, Ratko [1 ]
Katic, Vuka [1 ]
Milentijevic, Maja [1 ]
Velickovic, Ljubinka [1 ]
Krstic, Miljan [1 ]
机构
[1] Fac Med, Inst Pathol, Nish, Serbia
[2] Fac Med, Inst Physiol, Nish, Serbia
关键词
phyllodes tumor; Ki-67antigen receptors; estrogen; receptors; progesterone; genes; erbB-2; mast cells; leucyl aminopeptidase; breast neoplasms; diagnosis; LOCAL RECURRENCE; BREAST-CANCER; C-KIT; EXPRESSION; ENDOTHELIN-1; RECEPTOR; THERAPY; LESIONS;
D O I
10.2298/VSP0904277I
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background/Aim. Mammary phyllodes tumors (MPT) are Uncommon Fibroepithelial (biphasic) neoplasms whose clinical behavior is difficult to predict on the basis of histological criteria only. They are divided into benign, borderline malignant and malignant groups. Sometimes it appears difficult to distinguish these tumors from other types of soft tissue sarcomas. Because of the relatively scant data on the role of biological markers in MPT histogenesis, we have decided to undertake the following study, trying to shed more light on the issue by investigating the following elements that make up NIPT: their histological patterns, biological behavior, enzymohistochemical, histochemical and immunohistochemical characteristics (ICH) together with the mast cell analysis. Methods. We examined the biopsy material of 35 NIPT in Our laboratory. Enzymohistochemistry was performed on frozen sections (method of Crowford, Nachlas and Seligman). The used methods were classical hematoxylin-eosin (H & E); histochemical Massontrichrome, Alcian-blue, Periodic acid Schiff and immunohistochemical LSAB2 method (DacoCytomation). Ki-67, c-kit, vimentin, estrogen receptor (F-R), progesterone receptor (PR) and Her-2 oncoprotein immunohistochemistry was performed on all tumors. Results. The patients were ranged per age from 30-62 years (mean 43.3 years, median 39 years). A total of 35 cases of MPT were included: 20 benign (57%), 6 borderline malignant (17%) and 9 malignant (26%). Twenty-two patients (62.8%) underwent: segmental mastectomy, while 13 (37.2%) had total mastectomies. Twenty-eight patients had negative surgical margins at original resection. The mean size of malignant MPT (7.8 cm) was larger than that of benign MPT (4.5 cm). Significant features of the malignant MPT were: stromal cellularity, stromal cellular atypism, high mitotic activity, atypic mitoses, stromal overgrowth, infiltrative tumor contour and heterologous stromal elements. Benign MPT showed strong enzymohistochemical Leucine Amino Peptidase (LAP) activity in both epithelial and stromal components while it was weak or absent in the epithelial parts of the malignant tumors, Acid mucopolysacharides were present in the stromal component of all types of these tumors. Benign MPT had a lower Ki-67 than did borderline malignant MPT (4 versus 28). Malignant MPT had a greater than 8-fold higher Ki-67 activity than did benign tumors (35 versus 4). Intracytoplasmatic c-kit expression was associated with a pathological diagnosis of malignant MPT, correlating with increasing grade (p < 0.05). In hypercellular stroma of borderline malignant and especially malignant forms of MPT, high activity of ER in mast cells was confirmed. Oncoprotein Her-2 activity, mostly in epithelial components, correlated with the degree of malignant progression of MPT (b < 0.05). Conclusion. Besides the well-known malignant features additional parameters have been found to be high Ki-67 and c-kit stromal expressions, and weak LAP activity in the epithelial part of malignant M-PT, as well as mast cells with a high expression of ER.
引用
收藏
页码:277 / 282
页数:6
相关论文
共 50 条
  • [31] Fine needle aspiration cytologic features of mammary phyllodes tumors
    Tse, GMK
    Ma, TKF
    Pang, LM
    Cheung, H
    ACTA CYTOLOGICA, 2002, 46 (05) : 855 - 863
  • [32] Comprehensive genomic profiling of malignant phyllodes tumors of the breast
    Nozad, Sahar
    Sheehan, Christine E.
    Gay, Laurie M.
    Elvin, Julia A.
    Vergilio, Jo-Anne
    Suh, James
    Ramkissoon, Shakti
    Schrock, Alexa B.
    Hirshfield, Kim M.
    Ali, Nadia
    Ganesan, Shridar
    Ali, Siraj M.
    Miller, Vincent A.
    Stephens, Philip J.
    Ross, Jeffrey S.
    Chung, Jon H.
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 162 (03) : 597 - 602
  • [33] Increased p53 protein expression in malignant mammary phyllodes tumors (vol 15, pg 734, 2002)
    Tse, GMK
    Putti, TC
    Kung, FYL
    Scolyer, RA
    Law, BKB
    Lau, TS
    Lee, CS
    MODERN PATHOLOGY, 2002, 15 (09) : 1010 - 1010
  • [34] Malignant phyllodes tumor composed almost exclusively of a fibrosarcomatous component: a case report and review of malignant phyllodes tumors with metastases
    Satomi Suzuki-Uematsu
    Kazuko Shiraishi
    Taro Ito
    Naoki Adachi
    Yoshihisa Inage
    Yoshinori Taeda
    Hamaichi Ueki
    Haruo Ohtani
    Breast Cancer, 2010, 17 : 218 - 224
  • [35] Giant malignant mammary phyllodes tumor: Report of a case and review of the literature
    Hsu, Sheng-Der
    Chou, Shao-Jiun
    Hsieh, Huan-Fa
    Chen, Teng-Wei
    Cheng, Ming-Fang
    Yu, Jyh-Cherng
    ONKOLOGIE, 2007, 30 (1-2): : 45 - 47
  • [36] Margin negative, breast conserving resection: adequate for benign phyllodes tumors, but inadequate therapy for borderline and malignant phyllodes tumors
    Richard J. Barth
    Breast Cancer Research and Treatment, 2013, 142 : 463 - 464
  • [37] Phyllodes Tumors-The Predictors and Detection of Recurrence
    Lim, Robert S.
    Cordeiro, Erin
    Lau, Jaqueline
    Lim, Andrew
    Roberts, Amanda
    Seely, Jean
    CANADIAN ASSOCIATION OF RADIOLOGISTS JOURNAL-JOURNAL DE L ASSOCIATION CANADIENNE DES RADIOLOGISTES, 2021, 72 (02): : 251 - 257
  • [38] Margin negative, breast conserving resection: adequate for benign phyllodes tumors, but inadequate therapy for borderline and malignant phyllodes tumors
    Barth, Richard J., Jr.
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 142 (02) : 463 - 464
  • [39] Malignant phyllodes tumor composed almost exclusively of a fibrosarcomatous component: a case report and review of malignant phyllodes tumors with metastases
    Suzuki-Uematsu, Satomi
    Shiraishi, Kazuko
    Ito, Taro
    Adachi, Naoki
    Inage, Yoshihisa
    Taeda, Yoshinori
    Ueki, Hamaichi
    Ohtani, Haruo
    BREAST CANCER, 2010, 17 (03) : 218 - 224
  • [40] Management of malignant phyllodes tumors of the breast: The experience of the Institut Curie
    Haberer, S.
    Lae, M.
    Seegers, V.
    Pierga, J. -Y.
    Salmon, R.
    Kirova, Y. M.
    Dendale, R.
    Campana, F.
    Reyal, F.
    Miranda, O.
    Fourquet, A.
    Bollet, M. -A.
    CANCER RADIOTHERAPIE, 2009, 13 (04): : 305 - 312